{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:50:05Z","timestamp":1777945805266,"version":"3.51.4"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,2]]},"DOI":"10.1093\/ejhf\/xuag021","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:34:32Z","timestamp":1768566872000},"page":"113-114","source":"Crossref","is-referenced-by-count":0,"title":["Response to \u2018Interpreting tafamidis effectiveness within the evolving phenotype of contemporary ATTRwt cardiomyopathy\u2019"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-0825","authenticated-orcid":false,"given":"Aldostefano","family":"Porcari","sequence":"first","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste , Via P. Valdoni 7, Trieste 34100 ,","place":["Italy"]},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart , Trieste ,","place":["Italy"]},{"name":"Division of Medicine, National Amyloidosis Centre, University College London, Royal Free Hospital , London ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-3131","authenticated-orcid":false,"given":"Marco","family":"Merlo","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste , Via P. Valdoni 7, Trieste 34100 ,","place":["Italy"]},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart , Trieste ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2700-8478","authenticated-orcid":false,"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste , Via P. Valdoni 7, Trieste 34100 ,","place":["Italy"]},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart , Trieste ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2026050209114453700_xuag021-B1","doi-asserted-by":"crossref","DOI":"10.1093\/ejhf\/xuag020","article-title":"Interpreting tafamidis effectiveness within the evolving phenotype of contemporary ATTRwt cardiomyopathy","author":"Liu","year":"2026","journal-title":"Eur J Heart Fail"},{"key":"2026050209114453700_xuag021-B2","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1002\/ejhf.70071","article-title":"Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis","volume":"27","author":"Porcari","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026050209114453700_xuag021-B3","doi-asserted-by":"publisher","first-page":"101232","DOI":"10.1016\/j.jacadv.2024.101232","article-title":"Impact of the noninvasive diagnostic algorithm on clinical presentation and prognosis in cardiac amyloidosis","volume":"3","author":"Tini","year":"2024","journal-title":"JACC Adv"},{"key":"2026050209114453700_xuag021-B4","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation"},{"key":"2026050209114453700_xuag021-B5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jamacardio.2024.5221","article-title":"Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration","volume":"10","author":"Porcari","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2026050209114453700_xuag021-B6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jaccao.2024.12.005","article-title":"A multicenter study of contemporary long-term tafamidis outcomes in transthyretin amyloid cardiomyopathy","volume":"7","author":"Masri","year":"2025","journal-title":"JACC CardioOncol"},{"key":"2026050209114453700_xuag021-B7","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1002\/ejhf.3696","article-title":"Long-term efficacy of tafamidis in patients with transthyretin amyloid cardiomyopathy by National Amyloidosis Centre stage","volume":"27","author":"Damy","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026050209114453700_xuag021-B8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10741-024-10444-4","article-title":"Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis","volume":"30","author":"Girard","year":"2025","journal-title":"Heart Fail Rev"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/advance-article-pdf\/doi\/10.1093\/ejhf\/xuag021\/66503485\/xuag021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/28\/1\/113\/66503485\/xuag021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/28\/1\/113\/66503485\/xuag021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:11:48Z","timestamp":1777727508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/28\/1\/113\/8434491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,21]]},"published-print":{"date-parts":[[2026,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ejhf\/xuag021","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]}}}